According to the US Centers for Disease Control and Prevention, 91 Americans die every day from opioid overdoses - deaths caused when opiates like oxycontin, heroin and fentanyl slow and eventually stop a person's breathing.
The research shows that a range of compounds can deliver pain-blocking potency without affecting respiration, said Laura M Bohn, Professor at The Scripps Research Institute (TSRI) in the US.
The study builds on two decades of research which questioned whether the painkilling pathway, called the G protein pathway, could be unlinked from the breathing suppression pathway, called the beta-arrestin pathway.
Researchers developed new potential drug molecules; they then tweaked their chemical structures to systematically vary the "bias" between the two pathways - G protein signalling and beta-arrestin recruitment.
They developed more than 500 compounds in the past six years, and found more than 60 that showed bias between signalling assays.
The researchers then selected six compounds to represent a wide range in the degree of bias (from those that preferred barrestin recruitment to those that almost exclusively preferred G protein signalling) and determined their overall potency for inducing analgesia and respiratory suppression in mouse models.
The compounds that were less able to promote barrestin associations in cells were also less likely to induce respiratory suppression in mice.
In contrast, the painkiller fentanyl was shown to prefer receptor-barrestin associations and also had a more narrow safety margin.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
